NASS is regularly updating their website with relevant COVID-19 information including how patients can assess their risk, medicines and biologic therapy, mental health and the effect of the virus on work and benefits.
www.nass.co.uk/covid19
Aspiring to Excellence programme 2020 open for applications
Following a successful start for the first cohort, applications are now open for the Aspiring to Excellence programme in 2020. The programme is designed to encourage and recognise service improvement in axial SpA (AS) care and is a strategic partnership between NASS, BRITSpA and sponsoring companies AbbVie, Biogen, Novartis and UCB.…
Read more of this article
Many people with rheumatoid arthritis (RA) and their families will be concerned about how the Coronavirus (COVID-19) affects them. NRAS has provided a summary of all the important information that you need to know about Coronavirus and rheumatoid arthritis, including:
When people are scared they do one of two things – reach out for support and support others, or look after number one. We’ve seen lots of examples of both recently. ARMA members have chosen the first approach. They’ve been sharing information, working together to solve some common problems such as how to advise healthcare professionals working in private practice.
NICE has produced new, rapid guidelines on the active management of COVID-19 infection, which are likely to include patients with rheumatoid arthritis. NICE is also reviewing guidance on ibuprofen and other non-steroidal anti-inflammatory drugs in relation to impact on Covid-19 illness. Please see this page: 
Chronic (persistent or long-lasting or recurrent) pain significantly impacts individuals, their families and carers. For people with pain, the day-to-day concerns of living with and managing pain are of the highest importance, more so than the underlying condition. Here are some resources on pain available to people at home.